BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 22, 2012
View Archived Issues
Cardiosphere-derived autologous stem cells tested in patients with myocardial infarction
Read More
U.S. scientists design logic-gated DNA nanorobots for targeted drug delivery
Read More
Novel USP14 inhibitors presented by Harvard College
Read More
Bayer Schering Pharma discloses new soluble guanylate cyclase inhibitors
Read More
Boehringer Ingelheim patents new cannabinoid CB2 receptor ligands
Read More
Cephalon prepares novel IL-23-binding proteins
Read More
Novel antimalarial vaccines designed at Polish university
Read More
SGX-202 shows promise in model of gastrointestinal acute radiation syndrome
Read More
Gentium responds to EMA's day 120 list of questions for defibrotide MAA
Read More
S1 Pharmaceuticals submits IND application for SIP-104
Read More
Oral cardiac muscle myosin activator enters phase I trial
Read More
Jubilant and Mnemosyne enter collaboration
Read More
Full BOLERO-2 study results published
Read More
FDA grants priority review to Repligen NDA
Read More
Canadian distribution agreement set for tesamorelin
Read More
PCI Biotech begins treatment in Amphinex study
Read More
Ligand Pharmaceuticals enters new licensing agreement
Read More
Nuvo Research provides regulatory update on anesthetic cream
Read More
Nippon Kayaku anticancer drugs approved for additional indications in Japan
Read More
Preparations begin for European trial of NX-1207
Read More
Phase II/III trial to evaluate RLX-030 following acute heart failure
Read More
New site added to phase II trial of Telcyta
Read More
Novartis seeks line extension for Diovan
Read More
Salix begins phase III trial to assess repeated rifaximin treatment
Read More